OTCMKTS:CSNVY Corbion (CSNVY) Stock Price, News & Analysis $18.75 0.00 (0.00%) As of 04/23/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesShort InterestBuy This Stock About Corbion Stock (OTCMKTS:CSNVY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Corbion alerts:Sign Up Key Stats Today's Range$18.75▼$18.7550-Day Range$18.75▼$24.0052-Week Range$18.75▼$28.56Volume4 shsAverage Volume222 shsMarket CapitalizationN/AP/E Ratio35.94Dividend Yield3.58%Price TargetN/AConsensus RatingN/A Company OverviewCorbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was incorporated in 1919 and is headquartered in Amsterdam, the Netherlands.Read More… Receive CSNVY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Corbion and its competitors with MarketBeat's FREE daily newsletter. Email Address CSNVY Stock News HeadlinesCorbion announces strong first quarter 2025 results, well on track to deliver full-year outlookApril 23 at 9:56 AM | finance.yahoo.comHedge Fund Veteran Jeff Ubben Urges Corbion to Explore BreakupApril 22 at 5:49 PM | msn.comTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…April 24, 2025 | Crypto 101 Media (Ad)Corbion N.V.'s (AMS:CRBN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?April 22 at 3:34 AM | finance.yahoo.comBerenberg Bank downgrades Corbion NV (0QHL) to a SellApril 15, 2025 | markets.businessinsider.comCorbion's (AMS:CRBN) Upcoming Dividend Will Be Larger Than Last Year'sApril 5, 2025 | finance.yahoo.comCorbion publishes Annual Report 2024, marking its first CSRD-compliant Annual ReportMarch 24, 2025 | finance.yahoo.comCorbion Releases First CSRD-Compliant Annual ReportMarch 24, 2025 | tipranks.comSee More Headlines CSNVY Stock Analysis - Frequently Asked Questions How have CSNVY shares performed this year? Corbion's stock was trading at $22.60 at the beginning of the year. Since then, CSNVY shares have decreased by 17.0% and is now trading at $18.75. View the best growth stocks for 2025 here. How do I buy shares of Corbion? Shares of CSNVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorBasic Materials Industry Specialty Chemicals Sub-IndustryN/A Current SymbolOTCMKTS:CSNVY CIKN/A Webwww.corbion.com Phone(120) 590-6911FaxN/AEmployees2,573Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio35.94 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (OTCMKTS:CSNVY) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbion Please log in to your account or sign up in order to add this asset to your watchlist. Share Corbion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.